| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.00096 | 1 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | 0.00076 | 1 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.00066 | 1 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.0008 | 1 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.00058 | 1 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.00061 | 1 |